Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

ABRAXANE Approved For Advanced Breast Cancer Patient Treatment In Quebec
Abraxis BioScience, Inc. (NASDAQ:ABII), an integrated biotechnology company, announced the listing of ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast cancer with a recommendation from the Quebec Conseil du Mç©dicament and approval from the Quebec Ministry of Health. ABRAXANE is approved and commercially available in Canada for the treatment of metastatic breast cancer, including first-line disease. The listing of ABRAXANE in Quebec offers an important new treatment option to Quebec women with advanced breast cancer.
generic viagra online
Relief Efforts For Displaced People In Pakistan Barely Coping, Report Says
Despite significant efforts from Pakistani authorities and humanitarian organizations to respond to the world"s largest and fastest displacement of people in more than a decade, relief efforts are barely coping, according to an Oxfam report published on Monday, the International News reports.
News of the day
LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs Of Clinical Benefit
Santaris Pharma announced that the cancer drug EZN-2968 - an inhibitor of HIF-1alpha, jointly developed by Enzon Pharmaceuticals and Santaris Pharma A/S - was well tolerated and showed early signs of clinical benefit in previously treated cancer patients with advanced malignancies. EZN-2968 is being evaluated in patients with solid tumors and lymphoma. The study data, which was presented at the 2009 American Society of Clinical Oncology (ASCO) annual meeting in Florida last week, demonstrated that EZN-2968 is well tolerated, and that early signs of clinical benefit - prolonged stable disease - were observed in several patients.
Endocrinology

California State Senators Join Forces To Promote "Patient Safety Act"

Senator Sam Aanestad (R-Grass Valley) and Senator Gloria Negrete McLeod (D-Chino) are teaming up in an act of bi-partisan cooperation to serve as joint authors for legislation designed to improve patient safety in California by reforming Medical Peer Review. This is the process where a committee of physicians examines the work of a peer and determines whether the physician under review has met accepted standards of care in rendering medical services. Senator Aanestad and Senator Negrete McLeod, both of whom serve on the Senate Health Committee, agree that changes are needed because they believe the current system does not fully identify doctors who have delivered substandard medical care in California. Both legislators have agreed to serve as authors for SB 820. "Changes are needed to allow earlier identification of problems that endanger patients," said Senator Aanestad. "I"m pleased that Senator Negrete McLeod and I have agreed to a set of needed reforms that places patient safety first." The Medical Peer Review process is intended to detect incompetent or unprofessional physicians early and terminate, suspend or limit their practice if necessary. These cases can be triggered by a wide variety of events including patient injury, gross negligence and substance abuse. A peer review committee investigates the allegation, comes to a decision regarding the physician"s conduct and takes appropriate remedial actions. "Patients expect physicians or other medical professionals to be competent, qualified and trustworthy," said Senator Negrete McLeod. "Physicians who fail to meet established professional standards must be discovered, reviewed and disciplined, if necessary, in a timely manner." Senator Aanestad and Senator Negrete McLeod introduced separate bills following the conclusion of several studies that were critical of the medical peer review process, including the 2008 Lumetra Comprehensive Study of Peer Review in California and a congressional investigation on Peer Review. The Lumetra study, for example, concluded that "the present peer review system is broken for various reasons and is in need of a major fix, if the process is to truly serve the citizens of California." Furthermore, the congressional investigation found that "̣€¦the legislation governing the federal and state regulatory agencies so inadequate that prompt amendment of laws and regulations to protect the public is imperative." "This bipartisan measure provides the framework to improve patient safety," said Senator Aanestad. "Peer review must be conducted fairly but thoroughly, and patient safety must always be the top priority." The Office of Senator Sam Aanestad


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009